摘要
目的观察中药制剂清开灵注射液治疗小儿急性上呼吸道感染的临床疗效和安全性。方法将患儿随机分为试验组(清开灵注射液组48例)和对照组(病毒唑注射液组47例),2组对症治疗相同,试验组给予静滴清开灵注射液0.8mL/(kg.d),对照组给予静脉滴注病毒唑注射液10～15mg/(kg.d),均每天1次,3～5天为1个疗程。结果试验组总有效率为97.92%,对照组总有效率为72.34%,两组差异有统计学意义(P<0.01)。2组均未出现不良反应。结论清开灵注射液治疗小儿急性上呼吸道感染,未发现明显副作用,安全有效,优于病毒唑注射液。
Objective To observe the clinical effect and safety of qingkailing injecta on children＇s acute upper respiratory infection.Method The child patients were randomly divided into the experimental group,48 cases treated with qingkailing injecta 0.8 mL/（kg·d）,and the control group,47 cases treated with bingduzuo injecta 10～15 mg/（kg·d）,once a day,3～5 days for a period.Besides this,the two groups received the same symptomatic threatment.Results The total effective rate is 97.92% in experimental group and 72.34% in the control group （P〈0.01）.There were no adverse reactions in two groups.Conclusion Qingkailing injecta is safe and effective on children＇s acute upper respiratory infection,with no adverse reactions,having superiority over bingduzuo injecta.
出处
《保健医学研究与实践》
2010年第2期41-42,共2页
Health Medicine Research and Practice
关键词
小儿急性上呼吸道感染
清开灵
病毒唑
Children＇s acute upper respiratory infection
Qingkailing injecta
Bingduzuo injecta
